Parikh S, Koch M, Narayan RK. Traumatic brain injury. International anesthesiology clinics. 2007;45(3):119-35.

Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):56-87.

Kiah M, Azimi A, Hajisoltani R, Yousefifard M. Treatment with Rapamycin in Animal Models of Traumatic Brain Injuries; a Systematic Review and Meta-Analysis. Archives of Academic Emergency Medicine.12(1):e16-e.

Dinsmore J. Traumatic brain injury: an evidence-based review of management. Continuing Education in Anaesthesia, Critical Care & Pain. 2013;13(6):189-95.

Laalo JP, Kurki TJ, Sonninen PH, Tenovuo OS. Reliability of diagnosis of traumatic brain injury by computed tomography in the acute phase. J Neurotrauma. 2009;26(12):2169-78.

Maas AI, Menon DK, Manley GT, Abrams M, Åkerlund C, Andelic N, et al. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. The Lancet Neurology. 2022;21(11):1004-60.

Isokuortti H, Iverson GL, Silverberg ND, Kataja A, Brander A, Öhman J, et al. Characterizing the type and location of intracranial abnormalities in mild traumatic brain injury. J Neurosurg. 2018;129(6):1588-97.

Haydel MJ, Preston CA, Mills TJ, Luber S, Blaudeau E, DeBlieux PM. Indications for computed tomography in patients with minor head injury. N Engl J Med. 2000;343(2):100-5.

Forouzannia SM, Najafimehr H, Oskooi RK, Faridaalaee G, Dizaji SR, Toloui A, et al. Clinical decision rules in predicting computed tomography scan findings and need for neurosurgical intervention in mild traumatic brain injury: a prospective observational study. European Journal of Trauma and Emergency Surgery. 2023:1-9.

Ahmadi S, Dizaji SR, Babahajian A, Alizadeh M, Sarveazad A, Yousefifard M. Serum glial fibrillary acidic protein in detecting intracranial injuries following minor head trauma; a systematic review and meta-analysis. Archives of academic emergency medicine. 2023;11(1).

Gutierre MU, Telles JPM, Welling LC, Rabelo NN, Teixeira MJ, Figueiredo EG. Biomarkers for traumatic brain injury: a short review. Neurosurg Rev. 2021;44(4):2091-7.

Undén J, Ingebrigtsen T, Romner B. Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med. 2013;11:50.

Kato J, Svensson CI. Chapter Nine - Role of Extracellular Damage-Associated Molecular Pattern Molecules (DAMPs) as Mediators of Persistent Pain. In: Price TJ, Dussor G, editors. Progress in Molecular Biology and Translational Science. 131: Academic Press; 2015. p. 251-79.

Shakeri M, Mahdkhah A, Panahi F. S100B Protein as a Post-traumatic Biomarker for Prediction of Brain Death in Association With Patient Outcomes. Arch Trauma Res. 2013;2(2):76-80.

Glushakova OY, Glushakov AV, Mannix R, Miller ER, Valadka AB, Hayes RL. Chapter 8 - The Use of Blood-Based Biomarkers to Improve the Design of Clinical Trials of Traumatic Brain Injury. In: Skolnick BE, Alves WM, editors. Handbook of Neuroemergency Clinical Trials (Second Edition): Academic Press; 2018. p. 139-66.

Czeiter E, Amrein K, Gravesteijn BY, Lecky F, Menon DK, Mondello S, et al. Blood biomarkers on admission in acute traumatic brain injury: relations to severity, CT findings and care path in the CENTER-TBI study. EBioMedicine. 2020;56.

Carabias CS, Gomez PA, Panero I, Eiriz C, Castaño-León AM, Egea J, et al. YKL-40, SAA1, CRP and PCT are promising biomarkers for intracranial severity assessment of traumatic brain injury: relationship with Glasgow Coma Scale and CT volumetry. World Neurosurgery. 2019;134:e120-43.

Cervellin G, Benatti M, Carbucicchio A, Aloe R, Lippi G. Proteina S100B ed enolasi neurone-specifica nella valutazione iniziale del trauma cranico lieve nell’adulto: pronte per il debutto nel mondo reale? biochimica clinica. 2014;38(3):227.

Mussack T, Biberthaler P, Kanz KG, Heckl U, Gruber R, Linsenmaier U, et al. Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock. 2002;18(5):395-400.

Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, Todani M, et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. Journal of Trauma and Acute Care Surgery. 2010;69(1):104-9.

Raabe A, Grolms C, Seifert V. Serum markers of brain damage and outcome prediction in patients after severe head injury. Br J Neurosurg. 1999;13(1):56-9.

Ahmadi S, Roshdi Dizaji S, Babahajian A, Alizadeh M, Sarveazad A, Yousefifard M. Serum Glial Fibrillary Acidic Protein in Detecting Intracranial Injuries Following Minor Head Trauma; a Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2023;11(1):e9.

Rogan A, O'Sullivan MB, Holley A, McQuade D, Larsen P. Can serum biomarkers be used to rule out significant intracranial pathology in emergency department patients with mild traumatic brain injury? A Systemic Review & Meta-Analysis. Injury. 2022;53(2):259-71.

Amoo M, Henry J, O'Halloran PJ, Brennan P, Husien MB, Campbell M, et al. S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy. Neurosurg Rev. 2022;45(2):1171-93.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-36.

Lee J, Mulder F, Leeflang M, Wolff R, Whiting P, Bossuyt PM. QUAPAS: An Adaptation of the QUADAS-2 Tool to Assess Prognostic Accuracy Studies. Ann Intern Med. 2022;175(7):1010-8.

Gardner RC, Puccio AM, Korley FK, Wang KKW, Diaz-Arrastia R, Okonkwo DO, et al. Effects of age and time since injury on traumatic brain injury blood biomarkers: a TRACK-TBI study. Brain communications. 2023;5(1):fcac316.

Kaneko T, Era T, Karino K, Yamada S, Kitada M, Sakurai T, et al. Serum glial fibrillary acidic protein is a more specific biomarker than phosphorylated neurofilament heavy subunit, heart-fatty acidic pro-tein, neuron specific enolase, and S100B protein for CT-positive mild-to-moderate traumatic brain injury. Crit Care. 2019;22(6):307-12.

Shehab HA, Nassar YH. Neuromarkers as diagnostic adjuvant to cranial CT in closed traumatic brain injury patients admitted to ICU: a preliminary comparative study. Egyptian Journal of Anaesthesia. 2010;26(4):267-72.

Wolf H, Frantal S, Pajenda GS, Salameh O, Widhalm H, Hajdu S, et al. Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial. Journal of neurosurgery. 2013;118(6):1298-303.

Baker AJ, Rhind SG, Morrison LJ, Black S, Crnko NT, Shek PN, et al. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. J Neurotrauma. 2009;26(8):1227-40.

Chen J, Si L, Yao J, He L, Chen L, Deng Y, et al. Bi-spectral index values in predicting severity and prognosis in patients with diffuse axonal injuries. Int J Clin Exp Med. 2019;12(6):7766-71.

Chen M, Soosaipillai A, Fraser DD, Diamandis EP. Discovery of novel plasma biomarker ratios to discriminate traumatic brain injury. F1000Research. 2019;8.

Di Battista AP, Buonora JE, Rhind SG, Hutchison MG, Baker AJ, Rizoli SB, et al. Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome. Front Neurol. 2015;6:110.

Duda I, Wiórek A, Krzych Ł J. Biomarkers Facilitate the Assessment of Prognosis in Critically Ill Patients with Primary Brain Injury: A Cohort Study. Int J Environ Res Public Health. 2020;17(12).

Gao Y, Duan J, Ji H, Lu W. Levels of S100 calcium binding protein B (S100B), neuron-specific enolase (NSE), and cyclophilin A (CypA) in the serum of patients with severe craniocerebral injury and multiple injuries combined with delirium transferred from the ICU and their prognostic value. Ann Palliat Med. 2021;10(3):3371-8.

Gradisek P, Osredkar J, Korsic M, Kremzar B. Multiple indicators model of long-term mortality in traumatic brain injury. Brain Inj. 2012;26(12):1472-81.

McKeating EG, Andrews PJ, Mascia L. Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochir Suppl. 1998;71:117-9.

Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen LO. S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy. J Neurol Neurosurg Psychiatry. 2009;80(11):1241-7.

Raheja A, Sinha S, Samson N, Bhoi S, Subramanian A, Sharma P, et al. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial. J Neurosurg. 2016;125(3):631-41.

Rodríguez-Rodríguez A, Egea-Guerrero JJ, Gordillo-Escobar E, Enamorado-Enamorado J, Hernández-García C, Ruiz de Azúa-López Z, et al. S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury. Neurol Res. 2016;38(2):130-7.

Stein DM, Lindell AL, Murdock KR, Kufera JA, Menaker J, Bochicchio GV, et al. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury. Journal of neurotrauma. 2012;29(6):1140-9.

Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004;62(8):1303-10.

Zhang ZY, Zhang LX, Dong XQ, Yu WH, Du Q, Yang DB, et al. Comparison of the performances of copeptin and multiple biomarkers in long-term prognosis of severe traumatic brain injury. Peptides. 2014;60:13-7.

Peng C, Xing Y, Tao H, Yongbing D, Jingrui H. Role of Diffusion Tensor Imaging Combined with Neuron-Specific Enolase and S100 Calcium-binding Protein B Detection in Predicting the Prognosis of Moderate and Severe Traumatic Brain Injury. Iranian Red Crescent Medical Journal. 2021;23(4).

Wang X. CORRELATION BETWEEN SERUM NEURON SPECIFIC ENOLASE LEVEL AND NEURON INJURY INDEX AND NEURON APOPTOSIS INDEX IN PATIENTS WITH BRAIN INJURY. ACTA MEDICA MEDITERRANEA. 2021;37(2):791-4.

Mahan MY, Thorpe M, Ahmadi A, Abdallah T, Casey H, Sturtevant D, et al. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects. World Neurosurg. 2019;128:e434-e44.

Whitehouse DP, Monteiro M, Czeiter E, Vyvere TV, Valerio F, Ye Z, et al. Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: A CENTER-TBI study. EBioMedicine. 2022;75.

Olivecrona Z, Bobinski L, Koskinen L-OD. Association of ICP, CPP, CT findings and S-100B and NSE in severe traumatic head injury. Prognostic value of the biomarkers. Brain Injury. 2015;29(4):446-54.

Ahmadi S, Sarveazad A, Babahajian A, Ahmadzadeh K, Yousefifard M. Comparison of Glasgow Coma Scale and Full Outline of UnResponsiveness score for prediction of in-hospital mortality in traumatic brain injury patients: a systematic review and meta-analysis. European Journal of Trauma and Emergency Surgery. 2023;49(4):1693-706.

Chabok SY, Moghadam AD, Saneei Z, Amlashi FG, Leili EK, Amiri ZM. Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury. Journal of Trauma and Acute Care Surgery. 2012;72(6):1654-7.

Shenton ME, Hamoda HM, Schneiderman JS, Bouix S, Pasternak O, Rathi Y, et al. A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury. Brain Imaging Behav. 2012;6(2):137-92.

Thelin EP, Nelson DW, Bellander BM. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir (Wien). 2017;159(2):209-25.

Undén L, Calcagnile O, Undén J, Reinstrup P, Bazarian J. Validation of the Scandinavian guidelines for initial management of minimal, mild and moderate traumatic brain injury in adults. BMC medicine. 2015;13:1-9.

Pelinka LE, Hertz H, Mauritz W, Harada N, Jafarmadar M, Albrecht M, et al. Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings. Shock. 2005;24(2):119-23.

Johnsson P, Blomquist S, Lührs C, Malmkvist G, Alling C, Solem JO, et al. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg. 2000;69(3):750-4.

Thelin EP, Jeppsson E, Frostell A, Svensson M, Mondello S, Bellander BM, et al. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity. Crit Care. 2016;20:285.

Bramlett HM, Dietrich WD. Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes. J Neurotrauma. 2015;32(23):1834-48.

Zetterberg H, Blennow K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol. 2016;12(10):563-74.

Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert review of molecular diagnostics. 2018;18(2):165-80.

Quinones-Ossa GA, Padilla-Zambrano H, Pal R, Ghosh A, Moscote-Salazar LR, Kumar VK, et al. Biomarkers in acute brain trauma: a narrative review. Journal of Acute Disease. 2019;8(1):1-6.

Mercier E, Tardif P-A, Cameron PA, Batomen Kuimi BL, Emond M, Moore L, et al. Prognostic value of S-100β protein for prediction of post-concussion symptoms after a mild traumatic brain injury: systematic review and meta-analysis. Journal of Neurotrauma. 2018;35(4):609-22.

Yeung C, Bhatia R, Bhattarai B, Sinha M. Role of Salivary Biomarkers in Predicting Significant Traumatic Brain Injury: An Exploratory Study. Pediatr Emerg Care. 2021;37(12):e1373-e6.